Previous Video Next Video

Clinical Applications of Proton Pump Inhibitors (Part 2)

Duration: 41:11

Write A New Comment

2 Comments

mauro@*.com

May 08 2025, 8:56 pm

A very interesting subject, thank you

mauro@*.com

May 08 2025, 8:56 pm

A very interesting subject, thank you

This webinar expands on our discussion of proton pump inhibitors (PPIs) by examining their clinical applications and potential adverse effects. We will review the therapeutic use of PPIs in the management of acid-related disorders, including GERD, erosive esophagitis, gastric and duodenal ulcers, and Helicobacter pylori eradication. Additionally, we will discuss their role in treating pathological hypersecretory conditions such as Zollinger-Ellison syndrome and the prevention of NSAID-associated gastric ulcers.
The session will also cover the safety profile of PPIs, including short- and long-term adverse effects, potential drug interactions, and considerations for optimizing their use in clinical practice. Attendees will gain a comprehensive understanding of when and how to prescribe PPIs effectively while minimizing risks.

Learning Objectives:
Clinical Applications of Proton Pump Inhibitors (PPIs)
Adverse Effects of Proton Pump Inhibitors (PPIs).

Clinical Applications of Proton Pump Inhibitors (PPIs)
Adverse Effects of Proton Pump Inhibitors (PPIs).

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Faculty

In addition to the presenter, following authors may have helped with the content writing, review, or approval:

Dr. Mobeen Syed

CME, CE, CEU and Other Credit Types:

ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for Continuing Medical Education), we are committed to upholding principles of balance, independence, objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing Education (CE) activities. These policies include the careful management and mitigation of any relevant financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined that these relationships are not deemed inappropriate in the context of their respective presentations. Additionally, they are found to be consistent with the educational objectives and the integrity of the activity.

Faculty	Disclosures
Dr. Mobeen Syed	Author declares no conflict of interest.

Please login to access this content.

Don't have an account?

See Plans

Instructors

Dr. Mobeen Syed

MD., MSc., MSc., BSc

Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.